secwatch.observer — SEC 8-K summary
======================================

Issuer:     BRISTOL MYERS SQUIBB CO (BMY)
CIK:        0000014272
Form:       8-K
Filed at:   2022-03-17T23:59:59+00:00
Accession:  0001140361-22-009916
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Bristol-Myers appoints Sharon Greenlees as new SVP and Controller
-----------------------------------------------------------------

- Sharon Greenlees becomes Senior VP and Controller effective April 25, 2022; most recently at AbbVie as VP and Controller, R&D Finance.
- Karen Murphy Santiago, current SVP and Controller, will depart by May 1, 2022.
- Greenlees has a B.S. in Accounting and is a CPA.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/14272/000114036122009916/0001140361-22-009916-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/14272/000114036122009916/brhc10035347_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-22-009916

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer